Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hematologic Neoplasms × encorafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Melanoma 28 Colorectal Neoplasms 21 Colonic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Brain Neoplasms 7 Neoplasms 6 Neoplasm Metastasis 5 Skin Neoplasms 3 Rectal Neoplasms 3 Lung Neoplasms 3 Gastrointestinal Neoplasms 3 Pancreatic Neoplasms 2 Digestive System Neoplasms 2 Thyroid Neoplasms 1 Solid Tumors Harboring a BRAF V600 Mutation 1 Solid Tumors 1 Skin Diseases 1 Recurrence 1 Rectal Diseases 1 Neurofibromatosis 1 1 Multiple Myeloma 1 Lymphatic Metastasis 1 Leukemia, Hairy Cell 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Hereditary Sensory and Autonomic Neuropathies 1 Hematologic Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1

Interventions

Cyclophosphamide 75 fludarabine 68 fludarabine phosphate 41 Tacrolimus 39 Whole-Body Irradiation 38 Mycophenolic Acid 34 Busulfan 30 Melphalan 28 Methotrexate 21 Antilymphocyte Serum 21 thymoglobulin 20 Standard of Care 20 Thiotepa 19 Sirolimus 19 Rituximab 18 Azacitidine 17 venetoclax 16 Stem Cell Transplantation 16 Practice Guidelines as Topic 16 Granulocyte Colony-Stimulating Factor 16 Bortezomib 15 Cytarabine 14 Blood Specimen Collection 14 Filgrastim 13 Surveys and Questionnaires 12 Mesna 12 Specimen Handling 11 Nivolumab 10 Peripheral Blood Stem Cell Transplantation 9 Interviews as Topic 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01981187 2021-03-26

SIGNATURE

Pfizer

Phase 2 Terminated

12 enrolled 13 charts

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡